The Impact of the COVID-19 Pandemic on Osteoporosis Patients

被引:0
|
作者
Bozbas, Gulnur Tasci [1 ]
Donmez, Musa [2 ]
Omurlu, Imran Kurt [3 ]
Gurer, Gulcan [1 ]
机构
[1] Aydin Adnan Menderes Univ, Fac Med, Dept Phys Med & Rehabil, Aydin, Turkiye
[2] Aydin Ataturk State Hosp, Clin Phys Med & Rehabil, Aydin, Turkiye
[3] Aydin Adnan Menderes Univ, Fac Med, Dept Biostat, Aydin, Turkiye
来源
TURK OSTEOPOROZ DERGISI-TURKISH JOURNAL OF OSTEOPOROSIS | 2023年 / 29卷 / 03期
关键词
COVID-19; osteoporosis; osteoporosis treatment; VERTEBRAL FRACTURES; DISCONTINUATION; DENOSUMAB; MANAGEMENT; WOMEN;
D O I
10.4274/tod.galenos.2023.16443
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Osteoporosis is the most common metabolic bone disease associated with significant mortality and morbidity. The coronavirus disease-2019 (COVID-19) pandemic, which has affected the entire world, has necessitated curfews, quarantine measures, and alterations in hospital health services. Our study aimed to investigate the impact of the pandemic period on our osteoporosis patients. Materials and Methods: Ninety-two previously diagnosed osteoporosis postmenopausal female patients who presented to the outpatient clinic between July 20, 2020, and October 20, 2020, were enrolled in the study. Besides the patients' demographic characteristics, the duration of osteoporosis, the osteoporosis medications they used, and whether they interrupted the treatment during the pandemic period, and if they did, the reason was questioned. In addition, fracture history, fall frequency and exercise status were recorded before and during the pandemic. Results: The patients' mean age was 61 +/- 8 years. 10.9% had been exercising before the pandemic, and of these, 87.5% either reduced their exercise frequency or quit exercising during the pandemic. 20.7% of the patients before the pandemic and 17.4% during the pandemic period had a history of falling (p>0.05). When the continuation of osteoporosis treatment was analyzed, 7 (7.6%) patients were found to have interrupted their treatments during the pandemic. Of these, one of them had interrupted treatment due to the inability to obtain the medication, one of them had interrupted treatment due to not having the necessary investigations performed, and five patients had interrupted treatment because they could not leave their homes due to restrictions. It was observed that the interruption of drug treatment was not associated with those living in urban or countryside, or the level of osteoporosis knowledge (p>0.05). Conclusion: Our study demonstrated that the COVID-19 pandemic adversely affected osteoporosis patients' medication adherence and exercise levels. Therefore, we recommend taking preventive measures of addition existing ones in similar situations.
引用
收藏
页码:137 / 142
页数:6
相关论文
共 50 条
  • [1] Management of Osteoporosis During the COVID-19 Pandemic
    Tsourdi, Elena
    OSTEOLOGIE, 2022, 31 (01) : 31 - 37
  • [2] COVID-19 Pandemic and Osteoporosis in Elderly Patients
    Tang, Jun
    AGING AND DISEASE, 2022, 13 (04): : 960 - 969
  • [3] Osteoporosis in the age of COVID-19
    Girgis, C. M.
    Clifton-Bligh, R. J.
    OSTEOPOROSIS INTERNATIONAL, 2020, 31 (07) : 1189 - 1191
  • [4] COVID-19 Pandemic and Osteoporosis in Elderly Patients Comment
    Tang, Jun
    AGING AND DISEASE, 2021,
  • [5] Osteoporosis Management in the Era of COVID-19
    Yu, Elaine W.
    Tsourdi, Elena
    Clarke, Bart L.
    Bauer, Douglas C.
    Drake, Matthew T.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2020, 35 (06) : 1009 - 1013
  • [6] Osteoporosis during COVID-19 Pandemic
    Lam, R. H.
    Kumar, Jaya M.
    Naina, Isa M.
    Majmin, S. H.
    Rashidi, M. P. M.
    MEDICINE AND HEALTH, 2021, 16 (02): : 1 - 12
  • [7] Osteoporosis care during the COVID-19 pandemic in the Netherlands: A national survey
    Peeters, Josephine Jeanne Maria
    van den Berg, Peter
    van den Bergh, Joop P.
    Emmelot-Vonk, Marielle H.
    de Klerk, Gijs
    Lems, Willem F.
    Winter, Elizabeth M.
    Zillikens, M. Carola
    Appelman-Dijkstra, Natasha M.
    ARCHIVES OF OSTEOPOROSIS, 2021, 16 (01)
  • [8] Remote management of osteoporosis in the first wave of the COVID-19 pandemic
    Gianmaria Salvio
    Claudio Gianfelice
    Francesca Firmani
    Stefano Lunetti
    Rossella Ferroni
    Giancarlo Balercia
    Gilberta Giacchetti
    Archives of Osteoporosis, 2022, 17
  • [9] Remote management of osteoporosis in the first wave of the COVID-19 pandemic
    Salvio, Gianmaria
    Gianfelice, Claudio
    Firmani, Francesca
    Lunetti, Stefano
    Ferroni, Rossella
    Balercia, Giancarlo
    Giacchetti, Gilberta
    ARCHIVES OF OSTEOPOROSIS, 2022, 17 (01)
  • [10] Poor adherence to parenteral osteoporosis therapies during COVID-19 pandemic
    Roland Kocijan
    Martina Behanova
    Berthold Reichardt
    Judith Haschka
    Annemarie Kocijan
    Jochen Zwerina
    Archives of Osteoporosis, 2021, 16